Heat shock protein 90 inhibition sensitizes acute myelogenous leukemia cells to cytarabine. [electronic resource]
Producer: 20050801Description: 318-27 p. digitalISSN:- 0006-4971
- Antimetabolites, Antineoplastic -- pharmacology
- Benzoquinones
- Checkpoint Kinase 1
- Cytarabine -- pharmacology
- Drug Synergism
- HL-60 Cells
- HSP90 Heat-Shock Proteins -- antagonists & inhibitors
- Humans
- Lactams, Macrocyclic
- Leukemia, Myeloid, Acute -- drug therapy
- Protein Kinases -- genetics
- RNA, Small Interfering
- Rifabutin -- analogs & derivatives
- S Phase -- drug effects
No physical items for this record
Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.
There are no comments on this title.
Log in to your account to post a comment.